208 related articles for article (PubMed ID: 29661718)
1. The Gleason pattern 4 in radical prostatectomy specimens in current practice - Quantification, morphology and concordance with biopsy.
de Souza MF; de Azevedo Araujo ALC; da Silva MT; Athanazio DA
Ann Diagn Pathol; 2018 Jun; 34():13-17. PubMed ID: 29661718
[TBL] [Abstract][Full Text] [Related]
2. Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
Iakymenko OA; Lugo I; Briski LM; Nemov I; Punnen S; Kwon D; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML; Kryvenko ON
Prostate; 2021 Sep; 81(12):866-873. PubMed ID: 34184782
[TBL] [Abstract][Full Text] [Related]
3. PIN-like (Ductal) Adenocarcinoma of the Prostate.
Paulk A; Giannico G; Epstein JI
Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active Surveillance.
Hassan O; Han M; Zhou A; Paulk A; Sun Y; Al-Harbi A; Alrajjal A; Baptista Dos Santos F; Epstein JI
J Urol; 2018 Jun; 199(6):1482-1487. PubMed ID: 29154905
[TBL] [Abstract][Full Text] [Related]
5. High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy.
Chaux A; Fajardo DA; Gonzalez-Roibon N; Partin AW; Eisenberger M; DeWeese TL; Netto GJ
Urology; 2012 Apr; 79(4):863-8. PubMed ID: 22173174
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.
Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Franck Lissbrant I; Stattin P; Egevad L
Pathology; 2017 Dec; 49(7):715-720. PubMed ID: 29037803
[TBL] [Abstract][Full Text] [Related]
8. Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.
Diolombi ML; Epstein JI
BJU Int; 2017 Jun; 119(6):872-878. PubMed ID: 27496532
[TBL] [Abstract][Full Text] [Related]
9. Limited Adenocarcinoma of the Prostate on Needle Core Biopsy.
Bell PD; Teramoto Y; Gurung PMS; Yang Z; Miyamoto H
Arch Pathol Lab Med; 2022 Apr; 146(4):469-477. PubMed ID: 35020802
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy.
Yaxley W; Delahunt B; Yaxley J; Thunders MC; Kenwright DN; Egevad L; Samaratunga H
Pathology; 2022 Oct; 54(6):694-699. PubMed ID: 35613972
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Roobol MJ; Helleman J; van Leenders GJLH
Histopathology; 2020 Apr; 76(5):755-762. PubMed ID: 31944367
[TBL] [Abstract][Full Text] [Related]
12. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
[TBL] [Abstract][Full Text] [Related]
13. Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.
Dean LW; Assel M; Sjoberg DD; Vickers AJ; Al-Ahmadie HA; Chen YB; Gopalan A; Sirintrapun SJ; Tickoo SK; Eastham JA; Scardino PT; Reuter VE; Ehdaie B; Fine SW
J Urol; 2019 Jan; 201(1):77-82. PubMed ID: 30076908
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.
Epstein JI; Partin AW; Potter SR; Walsh PC
Urology; 2000 Aug; 56(2):283-8. PubMed ID: 10925095
[TBL] [Abstract][Full Text] [Related]
15. Tertiary Gleason pattern 5 on needle biopsy predicts greater tumour volume on radical prostatectomy.
Ranaweera M; Samaratunga H; Duffy D; Klopfer K; Brunelli M; Martignoni G; Delahunt B
Pathology; 2011 Dec; 43(7):693-6. PubMed ID: 22002115
[TBL] [Abstract][Full Text] [Related]
16. Gleason scores in prostate needle biopsy and prostatectomy specimens in prostatic adenocarcinoma: A correlation study.
Awang A; Md Isa N; Yunus R; Azhar Shah S; Md Pauzi SH
Malays J Pathol; 2019 Dec; 41(3):253-257. PubMed ID: 31901909
[TBL] [Abstract][Full Text] [Related]
17. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer.
Bostwick DG; Qian J; Bergstralh E; Dundore P; Dugan J; Myers RP; Oesterling JE
J Urol; 1996 Apr; 155(4):1361-7. PubMed ID: 8632575
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
[TBL] [Abstract][Full Text] [Related]
19. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
[TBL] [Abstract][Full Text] [Related]
20. The association between perineural invasion in mpMRI-targeted and/or systematic prostate biopsy and adverse pathological outcomes in robot-assisted radical prostatectomy.
Karsiyakali N; Bulent Ozgen M; Ozveren B; Akbal C; Dincer A; Durak H; Turkeri L
Actas Urol Esp (Engl Ed); 2022; 46(6):377-384. PubMed ID: 35260369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
